Showing results (621-630 of 708) with videos related to

Sort By:
Pageof 71
Chempluschem|February 19, 2026
Controlling the Arrangement of [Fe4L6]8+ Cages in the Solid StateMarco Pandullo, Aaron S Micallef, Aidan J Brock, et al.
Plos One|May 28, 2021
Sprouty4 negatively regulates ERK/MAPK signaling and the transition from in situ to invasive breast ductal carcinomaEthan J Brock, Ryan M Jackson, Julie L Boerner, et al.
JAMA|November 3, 2001
Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease: results from a quality improvement projectJ Brock, A Sauaia, D Ahnen, et al.
Human Mutation|January 1, 1992
Prevalence of cystic fibrosis mutations in the East German populationC Coutelle, R Brückner, K Grade, et al.
International Journal of Toxicology|September 27, 2021
Current Trends of Practices in Nonclinical Toxicology: An Industry SurveySimon Authier, William J Brock, Wendy Halpern, et al.
Biomedicines|September 27, 2025
In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular DegenerationAndrew J Kocab, Marisol Cano, Marianna Bacellar-Galdino, et al.
Transplantation|November 26, 1999
Intragraft overexpression of interleukin-4 is neither sufficient nor essential for tolerance induction to cardiac allografts in a high-responder strain combinationT Ritter, K Risch, G Schroder, et al.
Proteomics|March 5, 2004
Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometryAngel García, Sripadi Prabhakar, Chris J Brock, et al.
AJNR. American Journal of Neuroradiology|May 15, 2007
Embolectomy in a rabbit acute arterial occlusion model using a novel electromechanical extraction deviceJ Hartman, W Small, T S Wilson, et al.
Drug and Chemical Toxicology|December 5, 1998
Chronic toxicity, oncogenicity, and mutagenicity studies with chlorotetrafluoroethane (HCFC-124)L A Malley, S R Frame, G S Elliott, et al.
Pageof 71